vs
Side-by-side financial comparison of Autolus Therapeutics plc (AUTL) and Massimo Group (MAMO). Click either name above to swap in a different company.
Autolus Therapeutics plc is the larger business by last-quarter revenue ($21.2M vs $21.0M, roughly 1.0× Massimo Group). Massimo Group runs the higher net margin — 9.5% vs -373.3%, a 382.8% gap on every dollar of revenue.
Autolus Therapeutics plc is a clinical-stage biopharmaceutical company specializing in the development of next-generation engineered chimeric antigen receptor T-cell (CAR-T) therapies for the treatment of hematological malignancies and solid tumors. It operates in the global oncology biotech market, advancing a pipeline of targeted immunotherapy candidates across multiple clinical development stages.
Massimo Dutti, S.A. is a Spanish premium clothing retailer specializing in cashmere and wool products, established in 1985 and owned by Spanish multinational company Inditex, the parent company of Zara, Pull&Bear, and other brands.
AUTL vs MAMO — Head-to-Head
Income Statement — Q3 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $21.2M | $21.0M |
| Net Profit | $-79.1M | $2.0M |
| Gross Margin | — | 41.5% |
| Operating Margin | -337.9% | 13.1% |
| Net Margin | -373.3% | 9.5% |
| Revenue YoY | — | 15.7% |
| Net Profit YoY | 3.6% | 215.0% |
| EPS (diluted) | $-0.30 | $0.05 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $21.0M | ||
| Q3 25 | $21.2M | $17.0M | ||
| Q2 25 | $20.9M | $18.9M | ||
| Q1 25 | $9.0M | $14.9M | ||
| Q4 24 | — | $18.2M | ||
| Q3 24 | $0 | $25.6M | ||
| Q2 24 | $0 | $35.4M | ||
| Q1 24 | $10.1M | $30.2M |
| Q4 25 | — | $2.0M | ||
| Q3 25 | $-79.1M | $1.5M | ||
| Q2 25 | $-47.9M | $77.7K | ||
| Q1 25 | $-70.2M | $-2.1M | ||
| Q4 24 | — | $-1.7M | ||
| Q3 24 | $-82.1M | $-2.5M | ||
| Q2 24 | $-58.3M | $2.8M | ||
| Q1 24 | $-52.7M | $3.2M |
| Q4 25 | — | 41.5% | ||
| Q3 25 | — | 42.0% | ||
| Q2 25 | — | 36.3% | ||
| Q1 25 | — | 28.4% | ||
| Q4 24 | — | 19.6% | ||
| Q3 24 | — | 27.2% | ||
| Q2 24 | — | 32.5% | ||
| Q1 24 | — | 34.7% |
| Q4 25 | — | 13.1% | ||
| Q3 25 | -337.9% | 10.5% | ||
| Q2 25 | -292.6% | 0.8% | ||
| Q1 25 | -726.3% | -18.2% | ||
| Q4 24 | — | -15.4% | ||
| Q3 24 | — | 1.2% | ||
| Q2 24 | — | 10.1% | ||
| Q1 24 | -384.1% | 13.2% |
| Q4 25 | — | 9.5% | ||
| Q3 25 | -373.3% | 9.0% | ||
| Q2 25 | -229.0% | 0.4% | ||
| Q1 25 | -781.1% | -14.0% | ||
| Q4 24 | — | -9.5% | ||
| Q3 24 | — | -9.8% | ||
| Q2 24 | — | 8.0% | ||
| Q1 24 | -522.1% | 10.6% |
| Q4 25 | — | $0.05 | ||
| Q3 25 | $-0.30 | $0.04 | ||
| Q2 25 | $-0.18 | $0.00 | ||
| Q1 25 | $-0.26 | $-0.05 | ||
| Q4 24 | — | $-0.05 | ||
| Q3 24 | $-0.31 | $-0.06 | ||
| Q2 24 | $-0.22 | $0.07 | ||
| Q1 24 | $-0.24 | $0.08 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $86.1M | $5.8M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $265.5M | $23.7M |
| Total Assets | $661.9M | $51.4M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $5.8M | ||
| Q3 25 | $86.1M | $2.6M | ||
| Q2 25 | $123.8M | — | ||
| Q1 25 | $95.8M | $3.0M | ||
| Q4 24 | — | $10.2M | ||
| Q3 24 | $657.1M | — | ||
| Q2 24 | $705.9M | — | ||
| Q1 24 | $758.5M | — |
| Q4 25 | — | $23.7M | ||
| Q3 25 | $265.5M | $21.7M | ||
| Q2 25 | $346.5M | $20.2M | ||
| Q1 25 | $371.1M | $19.9M | ||
| Q4 24 | — | $21.7M | ||
| Q3 24 | $477.0M | $22.5M | ||
| Q2 24 | $527.8M | $24.7M | ||
| Q1 24 | $582.0M | $18.1M |
| Q4 25 | — | $51.4M | ||
| Q3 25 | $661.9M | $44.4M | ||
| Q2 25 | $721.0M | $45.9M | ||
| Q1 25 | $746.3M | $46.4M | ||
| Q4 24 | — | $54.9M | ||
| Q3 24 | $827.5M | $57.1M | ||
| Q2 24 | $853.6M | $49.9M | ||
| Q1 24 | $901.4M | $47.3M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-67.9M | $4.0M |
| Free Cash FlowOCF − Capex | $-72.3M | — |
| FCF MarginFCF / Revenue | -341.2% | — |
| Capex IntensityCapex / Revenue | 20.8% | — |
| Cash ConversionOCF / Net Profit | — | 2.01× |
| TTM Free Cash FlowTrailing 4 quarters | $-322.5M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $4.0M | ||
| Q3 25 | $-67.9M | $633.2K | ||
| Q2 25 | $-72.8M | $-1.4M | ||
| Q1 25 | $-75.6M | $-3.3M | ||
| Q4 24 | — | $9.1M | ||
| Q3 24 | $-76.7M | $4.7M | ||
| Q2 24 | $-51.1M | $-6.5M | ||
| Q1 24 | $-40.5M | $-637.0K |
| Q4 25 | — | — | ||
| Q3 25 | $-72.3M | — | ||
| Q2 25 | $-80.1M | — | ||
| Q1 25 | $-83.8M | — | ||
| Q4 24 | — | $9.0M | ||
| Q3 24 | $-86.3M | $4.6M | ||
| Q2 24 | $-51.9M | $-6.7M | ||
| Q1 24 | $-41.0M | $-741.4K |
| Q4 25 | — | — | ||
| Q3 25 | -341.2% | — | ||
| Q2 25 | -382.6% | — | ||
| Q1 25 | -933.1% | — | ||
| Q4 24 | — | 49.7% | ||
| Q3 24 | — | 18.1% | ||
| Q2 24 | — | -19.0% | ||
| Q1 24 | -406.8% | -2.5% |
| Q4 25 | — | — | ||
| Q3 25 | 20.8% | — | ||
| Q2 25 | 34.8% | — | ||
| Q1 25 | 91.8% | — | ||
| Q4 24 | — | 0.2% | ||
| Q3 24 | — | 0.3% | ||
| Q2 24 | — | 0.7% | ||
| Q1 24 | 5.3% | 0.3% |
| Q4 25 | — | 2.01× | ||
| Q3 25 | — | 0.41× | ||
| Q2 25 | — | -17.92× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | -2.30× | ||
| Q1 24 | — | -0.20× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
